News

HRC Press Release  Wednesday 15 September 2026 – Birmingham, UK - For more than two decades, Heart Rhythm Congress (HRC) has been at the forefront of education, discussion and collaboration in heart rhythm care. Organised by...

Abbott Press Release MISSISSAUGA, ON, Sept 15, 2026 — Abbott today announced that its Volt™ Pulsed Field Ablation System, designed to deliver more precise, targeted energy with fewer catheter exchanges and reduced radiation exposure than...

SAN FRANCISCO, Sep. 15, 2026 – Murj®, a cardiac device management software and services company, today announced its programming at HRX Live 2026, the Heart Rhythm Society’s annual innovation conference taking place September...

Santé Ventures Press Release SANTA ROSA, Calif., Sept. 11, 2026 -- Jaguar LAA, Inc. ("Jaguar"), a privately held medical device company, today announced the acquisition of assets related to the Laminar program, focused on...

ESC Press Release Sophia Antipolis, France – 10 September 2026: Exposure to light during the nighttime is linked to important and potentially harmful changes to the structure and function of the heart, according to a study of more...

Kardium Inc. Press Release VANCOUVER, British Columbia -- Kardium Inc., a medical device solutions company behind the Globe® System, announced the launch of the “Globe Durability Guarantee”™, which is designed to provide patients and...

LUMA Vision Press Release DUBLIN, Ireland, September 09, 2026 — LUMA Vision, a medtech company transforming minimally invasive cardiac procedures, today announced FDA clearance expanding the capabilities of VERAFEYE, its procedural...

Implicity Press Release  CAMBRIDGE, Mass. and PARIS, Sept. 09, 2026 -- Implicity, a global leader in AI-driven cardiac remote monitoring, has secured a $40 million funding round led by European tech growth capital firm IRIS, alongside...

ElectroWire Medical Press Release LEXINGTON, S.C., Sept. 9, 2026 - ElectroWire Medical, developer of the FDA-cleared LightningWire™ Transseptal Puncture System, today announced the successful completion of its first clinical cases,...

Bayer Press Release WHIPPANY, N.J. -- Bayer announced today the initiation of a global Phase II clinical trial (NCT07625215) evaluating BAY 3670549, an investigational highly selective G-protein-coupled inwardly rectifying potassium...